Profile data is unavailable for this security.
About the company
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.
- Revenue in CNY (TTM)25.34bn
- Net income in CNY1.07bn
- Incorporated1999
- Employees45.47k
- LocationDaShenLin Pharmaceutical Group Co LtdNo. 410410-1, Longxi Avenue, Liwan DistrictGUANGZHOU 510000ChinaCHN
- Phone+86 2 081689688
- Fax+86 2 081176091
- Websitehttp://www.dslyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kusuri No Aoki Holdings Co Ltd | 19.65bn | 400.79m | 13.68bn | 4.46k | 34.14 | 2.62 | 13.83 | 0.6965 | 91.29 | 91.29 | 4,475.41 | 1,191.11 | 1.56 | 7.00 | 42.38 | 94,923,100.00 | 3.18 | 6.14 | 4.60 | 9.49 | 27.35 | 28.26 | 2.04 | 3.66 | 0.7704 | 65.45 | 0.4247 | 6.37 | 15.39 | 11.35 | 25.28 | 6.92 | 7.90 | 12.63 |
LBX Pharmacy Chain JSC | 22.54bn | 958.95m | 20.44bn | 40.88k | 21.31 | 2.89 | -- | 0.9071 | 1.64 | 1.64 | 38.53 | 12.08 | 1.06 | 3.61 | 11.24 | 551,261.10 | 5.40 | 5.73 | 11.29 | 12.96 | 32.73 | 32.33 | 5.11 | 5.08 | 0.4795 | 13.19 | 0.557 | 33.18 | 11.21 | 18.83 | 18.35 | 16.39 | -6.60 | 19.16 |
Sugi Holdings Co Ltd | 34.55bn | 1.02bn | 21.50bn | 7.73k | 20.07 | 1.89 | 12.83 | 0.6222 | 121.46 | 121.46 | 4,114.16 | 1,289.59 | 2.01 | 6.52 | 18.18 | -- | 5.92 | 6.11 | 8.99 | 9.30 | 30.74 | 30.38 | 2.95 | 3.21 | 0.8443 | -- | 0.0036 | 23.94 | 11.51 | 8.79 | 15.64 | 4.14 | 12.58 | 2.71 |
Tsuruha Holdings Inc | 47.00bn | 1.26bn | 22.12bn | 11.30k | 17.35 | 1.65 | 10.05 | 0.4706 | 554.77 | 554.77 | 20,729.87 | 5,827.22 | 1.89 | 4.89 | 22.41 | 89,640,290.00 | 5.56 | 6.03 | 8.75 | 10.01 | 30.42 | 29.35 | 2.94 | 3.16 | 0.6803 | 38.96 | 0.1437 | 35.08 | 5.94 | 7.58 | 18.09 | 0.3683 | 21.98 | 12.23 |
Sundrug Co Ltd | 34.89bn | 1.35bn | 22.24bn | 6.37k | 16.12 | 1.86 | 14.23 | 0.6373 | 249.06 | 249.06 | 6,428.42 | 2,164.06 | 1.93 | 6.45 | 30.71 | -- | 7.46 | 7.88 | 11.37 | 11.55 | 25.18 | 24.86 | 3.87 | 3.82 | 0.7523 | -- | 0.1215 | 38.73 | 8.88 | 5.03 | 13.32 | 4.01 | 27.84 | 11.55 |
Welcia Holdings Co Ltd | 56.50bn | 1.23bn | 22.39bn | 14.87k | 18.00 | 2.00 | 9.48 | 0.3964 | 127.85 | 127.85 | 5,879.06 | 1,150.65 | 2.24 | 6.37 | 20.73 | -- | 4.84 | 5.76 | 8.27 | 10.23 | 30.40 | 30.81 | 2.16 | 2.51 | 0.5507 | 44.99 | 0.2529 | 23.81 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
Dashenlin Pharmaceutical Group Co Ltd | 25.34bn | 1.07bn | 26.13bn | 45.47k | 24.37 | 3.58 | -- | 1.03 | 0.9412 | 0.9412 | 22.41 | 6.41 | 1.09 | 3.84 | 23.18 | 557,261.80 | 4.99 | 6.57 | 10.07 | 12.63 | 34.87 | 37.51 | 4.58 | 5.54 | 0.6126 | 9.07 | 0.5772 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
Cosmos Pharmaceutical Corp | 43.47bn | 1.15bn | 26.19bn | 5.29k | 22.47 | 2.49 | 12.81 | 0.6026 | 627.89 | 627.89 | 23,646.83 | 5,659.54 | 2.32 | 9.86 | 2,065.50 | 177,071,100.00 | 6.16 | 7.02 | 10.96 | 13.37 | 19.65 | 20.03 | 2.66 | 3.18 | 0.1784 | 1,267.96 | 0.0456 | 12.24 | 9.57 | 8.21 | 2.77 | 6.18 | 9.63 | 17.32 |
Data as of May 17 2024. Currency figures normalised to DaShenLin Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
CITIC Securities Co., Ltd. (Invt Port)as of 30 Sep 2023 | 19.99m | 1.76% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 18.59m | 1.64% |
FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 2024 | 11.90m | 1.05% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 8.53m | 0.75% |
HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 6.18m | 0.54% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 4.88m | 0.43% |
Cinda Fund Management Co. Ltd.as of 31 Dec 2023 | 4.62m | 0.41% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 4.29m | 0.38% |
Harfor Fund Management Co., Ltd.as of 30 Jun 2023 | 4.25m | 0.37% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 4.16m | 0.37% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.